Welcome to our dedicated page for McKesson news (Ticker: MCK), a resource for investors and traders seeking the latest updates and insights on McKesson stock.
McKesson Corporation reports developments tied to its role as a diversified healthcare services company and major pharmaceutical distributor. Company news commonly covers fiscal results and guidance, dividend declarations, capital allocation, share repurchase activity, and updates across core distribution, oncology and multispecialty, biopharma services, pharmacy technology, and medical-surgical product categories.
McKesson updates also include portfolio actions and governance changes. Recent company materials document the completed divestiture of its Norwegian retail and distribution businesses, marking its exit from European operations, alongside recurring communications about earnings events, healthcare conferences, and leadership succession matters.
McKesson Corporation (NYSE:MCK) will announce its third quarter fiscal 2021 financial results on February 2, 2021, before market open. A live webcast of the earnings call will begin at 8:00 AM ET. The management will also participate in notable healthcare conferences, including the Goldman Sachs 13th Annual Healthcare CEOs Unscripted Conference on January 5, 2021, and the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021. Investors can access the webcast and financial materials on McKesson's Investor Relations website.
McKesson Corporation (NYSE:MCK) has appointed Dr. Kelvin A. Baggett as the new chief impact officer, effective November 30, 2020. This role aims to enhance the company's focus on diversity, equity, inclusion, sustainability, and social impact. Dr. Baggett brings extensive healthcare leadership experience, having previously served at Health Care Navigator and Tenet Healthcare. His appointment is expected to help McKesson align its strategies with societal needs, impacting both employees and communities positively.
McKesson Corporation (NYSE: MCK) has appointed Linda Mantia as an independent director, expanding its board from 11 to 12 members, effective October 19, 2020. Mantia brings over 25 years of experience in financial services and operations, having held leadership roles at Manulife Financial and Royal Bank of Canada. Her election is expected to enhance strategic guidance during critical times for healthcare. Mantia also serves on several boards and committees, positioning her to positively impact McKesson Canada's growth initiatives.
McKesson Corporation (NYSE:MCK) is set to release its second-quarter fiscal 2021 financial results on November 3, 2020, before market open. A live webcast will be conducted at 8:00 AM Eastern Time for investors to review the results. The webcast, along with the earnings press release and financial materials, will be accessible on McKesson’s Investor Relations website.
McKesson is recognized for providing healthcare supply chain management solutions and was named one of the Most Admired Companies in the healthcare wholesaler category by FORTUNE.